Szücs G, Rigó J, Rédai I
Debreceni Orvostudományi Egyetem Ortopédiai Klinika és Mikrobiológiai Intézet közleménye.
Magy Traumatol Ortop Kezseb Plasztikai Seb. 1994;37(3):245-9.
Authors report on the treatment of 20 chronic osteomyelitis patients in whom direct antibiotic therapy was performed using the preparation Péflacine. The infected area was exposed in every case, the bony focus was excised and the wound was drained. During the operation, as an induction 800 mg Péflacine in slow drop infusion was given. Oral preparation (2 x 400 mg/die) followed, and was continued for 30 days. The secretion of the wounds ceased in every case, after 3 weeks the latest. In 2 cases mild gastrointestinal symptoms as side effects were observed. Relapse the first time occurred 5-7 months after ending the treatment in 3 patients. These were again explored and after the excision more thorough than before the secretion ceased. According their experience and in conformity with the literature the Péflacine is held an effective medicament in the treatment of the acute exacerbation of chronic osteomyelitis, together with the excision of the focus.
作者报告了对20例慢性骨髓炎患者的治疗情况,这些患者使用培氟沙星制剂进行了直接抗生素治疗。在每例患者中均暴露感染区域,切除骨病灶并引流伤口。手术期间,静脉缓慢滴注800mg培氟沙星作为诱导治疗。随后口服制剂(每日2次,每次400mg),持续30天。所有伤口的分泌物均停止,最晚在3周后。观察到2例出现轻度胃肠道症状作为副作用。3例患者在治疗结束后5至7个月首次复发。再次对这些患者进行探查,切除病灶后比之前更彻底,分泌物停止。根据他们的经验并与文献一致,培氟沙星被认为是治疗慢性骨髓炎急性加重并切除病灶时的一种有效药物。